Sales/Maturities of Investments

$10.68B

TTM · Period ending: Jun 30, 2026 · USD

REGN Sales/Maturities of Investments

Latest reported$10.68Bperiod endingJun 30, 2026

REGN TTM Sales/Maturities of Investments ($82.80M → $10.68B)

TTM Sales/Maturities of Investments

High-resolution chart · PNG

REGN sales/maturities of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Sales/Maturities of Investments — Trailing twelve months (TTM) (USD)
Period ending	Sales/Maturities of Investments (USD)
Jun 30, 2026	10,675,100,000
Mar 31, 2026	10,694,400,000
Dec 31, 2025	11,546,200,000
Sep 30, 2025	11,573,200,000
Jun 30, 2025	12,466,800,000
Mar 31, 2025	14,353,400,000
Dec 31, 2024	15,027,300,000
Sep 30, 2024	14,828,200,000
Jun 30, 2024	13,567,400,000
Mar 31, 2024	11,781,600,000
Dec 31, 2023	9,442,200,000
Sep 30, 2023	8,596,700,000
Jun 30, 2023	7,430,600,000
Mar 31, 2023	6,597,000,000
Dec 31, 2022	5,550,500,000
Sep 30, 2022	4,331,100,000
Jun 30, 2022	3,179,600,000
Mar 31, 2022	2,545,300,000
Dec 31, 2021	2,215,300,000
Sep 30, 2021	2,352,000,000
Jun 30, 2021	2,158,400,000
Mar 31, 2021	3,760,100,000
Dec 31, 2020	3,785,000,000
Sep 30, 2020	3,628,100,000
Jun 30, 2020	3,702,000,000
Mar 31, 2020	1,707,000,000
Dec 31, 2019	1,604,200,000
Sep 30, 2019	1,437,897,000
Jun 30, 2019	1,059,288,000
Mar 31, 2019	858,724,000
Dec 31, 2018	775,600,000
Sep 30, 2018	809,412,000
Jun 30, 2018	734,630,000
Mar 31, 2018	680,848,000
Dec 31, 2017	544,584,000
Sep 30, 2017	461,640,000
Jun 30, 2017	444,445,000
Mar 31, 2017	333,059,000
Dec 31, 2016	274,456,000
Sep 30, 2016	253,533,000
Jun 30, 2016	235,845,000
Mar 31, 2016	307,390,000
Dec 31, 2015	327,437,000
Sep 30, 2015	525,934,000
Jun 30, 2015	514,336,000
Mar 31, 2015	474,404,000
Dec 31, 2014	476,417,000
Sep 30, 2014	275,472,000
Jun 30, 2014	226,752,000
Mar 31, 2014	405,861,000
Dec 31, 2013	378,146,000
Sep 30, 2013	497,591,000
Jun 30, 2013	574,572,000
Mar 31, 2013	418,110,000
Dec 31, 2012	439,209,000
Sep 30, 2012	362,596,000
Jun 30, 2012	381,606,000
Mar 31, 2012	444,058,000
Dec 31, 2011	426,356,000
Sep 30, 2011	370,618,000
Jun 30, 2011	355,323,000
Mar 31, 2011	270,393,000
Dec 31, 2010	276,601,000
Sep 30, 2010	242,990,000
Jun 30, 2010	244,597,000
Mar 31, 2010	279,076,000
Dec 31, 2009	297,411,000
Sep 30, 2009	488,208,000
Jun 30, 2009	597,731,000
Mar 31, 2009	597,046,000
Dec 31, 2008	646,861,000
Sep 30, 2008	607,017,000
Jun 30, 2008	513,303,000
Mar 31, 2008	546,416,000
Dec 31, 2007	527,169,000
Sep 30, 2007	408,189,000
Jun 30, 2007	464,626,000
Mar 31, 2007	355,144,000
Dec 31, 2006	306,199,000
Sep 30, 2006	299,315,000
Jun 30, 2006	211,060,000
Mar 31, 2006	232,380,000
Dec 31, 2005	223,448,000
Sep 30, 2005	217,447,000
Jun 30, 2005	288,607,000
Mar 31, 2005	256,579,000
Dec 31, 2004	277,909,000
Sep 30, 2004	282,200,000
Jun 30, 2004	202,493,000
Mar 31, 2004	237,141,000
Dec 31, 2003	253,315,000
Sep 30, 2003	302,825,000
Jun 30, 2003	281,602,000
Mar 31, 2003	263,902,000
Dec 31, 2002	215,831,000
Sep 30, 2002	177,443,000
Jun 30, 2002	154,057,000
Mar 31, 2002	145,099,000
Dec 31, 2001	124,189,000
Sep 30, 2001	93,024,000